We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
WCBA
1451
Weaver C. Barksdale & Associates
Tennessee
$821K
SAM
1452
Security Asset Management
New York
$820K -$8.27K -263 -1%
DIP
1453
DT Investment Partners
Pennsylvania
$816K +$10.6K +338 +1%
NFG
1454
Nations Financial Group
Iowa
$816K +$838K +26,634 New
NB
1455
Nicolet Bankshares
Wisconsin
$816K +$887K +28,198 New
MSFP
1456
Mark Sheptoff Financial Planning
Connecticut
$805K -$17.3K -551 -2%
EIA
1457
Edgemoor Investment Advisors
Maryland
$802K -$8.3K -264 -1%
SAM
1458
Sentinel Asset Management
Vermont
$801K
IC
1459
Intersect Capital
California
$798K +$77.7K +2,470 +10%
GWCM
1460
Godshalk Welsh Capital Management
Pennsylvania
$797K +$3.3K +105 +0.4%
PGA
1461
Portland Global Advisors
Maine
$795K +$70.4K +2,238 +9%
MKC
1462
M. Kraus & Co
Vermont
$793K -$11.6K -369 -1%
RP
1463
Reinhart Partners
Wisconsin
$792K -$1.8M -57,271 -69%
LMIM
1464
Lockheed Martin Investment Management
Maryland
$791K -$3.98M -126,480 -83%
TFCM
1465
Taylor Frigon Capital Management
Arizona
$791K +$7.93K +252 +1%
SIM
1466
SSI Investment Management
California
$790K
PCMC
1467
Paragon Capital Management (Colorado)
Colorado
$789K +$16.6K +527 +2%
SCI
1468
S&CO Inc
Massachusetts
$788K
MMG
1469
Monetary Management Group
Missouri
$786K +$74.6K +2,372 +10%
KL
1470
KWMG LLC
Kansas
$778K +$105K +3,336 +15%
MSR
1471
Main Street Research
Connecticut
$772K -$6.7K -213 -0.8%
FLPIM
1472
F.L. Putnam Investment Management
Massachusetts
$772K +$16K +510 +2%
AI
1473
Accredited Investors
Minnesota
$766K +$183K +5,818 +30%
SCA
1474
Stonebridge Capital Advisors
Minnesota
$764K +$56.1K +1,783 +8%
WIA
1475
Westbourne Investment Advisors
Maryland
$763K +$39.8K +1,265 +5%

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.